This week Wood Mackenzie, an Edinburgh-based research and consulting firm, reviews recent trends in biotechnology stocks. From mid-January, the Nasdaq Biotechnology Index set out on a gradual upward trajectory — only to be interrupted by a sharp drop in late February. This fall wasn't biotechnology-specific, however — it reflected the global market correction at the end of that month.
展开▼
